Chris Smith

Gyrus Group Ltd. designs, develops, manufactures and markets electro-surgical systems. It operates in four segments: surgical, urology, gynaecology, ent, and partnered technologies. The firm supplies medical devices which reduce trauma and complications in surgery and develops tissue management systems, instruments and services. Gyrus Group was founded in 1989 and is headquartered in London, the United Kingdom.

Ortho-Clinical Diagnostics, Inc. engages in the manufacture and design of diagnostic, transfusion, clinical equipment, and systems. It provides solutions for screening, diagnosing, monitoring, and confirming diseases early before they put lives at risk. Its products include instrument systems and reagents that screen for AIDS and hepatitis C, as well as blood typing systems. The company was founded in 1939 and is headquartered in Raritan, NJ.

Gyrus Medical Ltd. manufactures medical devices. It makes instruments used in minimally invasive surgical procedures which primarily focus on products used by general surgeons. The company is located in Cardiff, UK.

Ortho-Clinical Diagnostics Italy Srl manufactures and designs diagnostic, transfusion, and clinical equipment and systems. The firm provides total solutions for screening, diagnosing, monitoring and confirming diseases early before they put lives at risk. The company is headquartered in Milan, Italy.

Agilitas USA, Inc. engages in the provision of physical therapy services. The treatments it offers include dry needling therapy, manual therapy, and pelvic health speciality clinics. The company was founded by Garry Cunningham, Gregory Spurgin, and Tracy Caulkins in 1996 and is headquartered in Franklin, TN.

Neuromod Devices Ltd. operates as a medical device company which engages in the research and development of neuromodulation technologies for chronic tinnitus. The firm develops proprietary neuromodulation technologies designed to address pathologies, which are believed to give rise to illusory perceptions, such as tinnitus. These technologies utilize bi-modal neuromodulation and aim to promote positive therapeutic change within the human nervous system. The company was founded by Ross O?Neill in 2010 and is headquartered in Dublin, Ireland.

Akouos, Inc. is a precision genetic medicine company, which engages in the development of precision genetic medicines to restore and preserve hearing in genetically-defined patient populations. The firm's lead product candidate, AK-OTOF, is a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. It develops targeted adeno-associated viral vector based gene therapies for sensorineural hearing loss, which results from dysfunction or damage to sensory cells and nerve fibers of the inner ear. The company was founded by Emmanuel J. Simons, William F. Sewell, Richard H. Smith, Luk H. Vandenberghe, and Michael J. McKenna on March 7, 2016 and is headquartered in Boston, MA.

Osler Diagnostics Ltd. engages in research and development in biotechnology. The company was founded by Jason Davis and Paulo R. Bueno and is headquartered in Oxford, the United Kingdom.

Ortho Clinical Diagnostics Holdings Plc provides vitro diagnostics services. It offers VITROS XT 7600 Integrated System, VITROS 5600 Integrated System, VITROS 4600 Chemistry System, VITROS® XT 3400 Chemistry System, VITROS® 3600 Immunodiagnostic System, VITROS ECiQ Immunodiagnostic System, VITROS Automation Solutions, Informatics Solutions, Assay Menu by Disease State, Microtip Partnership Assays, VITROS HIV Combo Test, Transfusion Medicine, ORTHO VISION Analyzer, ORTHO VISION Max Analyzer, ORTHO CONNECT, ORTHO Workstation, Lab Reliability, Lab Optimization, Training & Education and Lab Support. The company was founded in 1997 and is headquartered in Raritan, NJ.